Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 131

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 7
Chunk 131
---
 and equipment(1,256)(1,296)(1,152)40 (144)Cash dividends(1,508)(1,395)(1,229)(113)(166)Other uses of cash, net(508)(80)— (428)(80)Total uses of cash(10,981)(9,699)(7,684)(1,282)(2,015)Effect of foreign exchange rates on cash and cash equivalents(6)(1)(14)(5)13 Net increase (decrease) in cash and cash equivalents$1,828 $(861)$2,507 $2,689 $(3,368)

Liquidity—Year Ended December 31, 2024 Compared to Year Ended December 31, 2023

The decline in cash provided by operating activities was primarily due to the impact of the membership decline in our Medicaid business and working capital changes. 

Other significant changes in sources and uses of cash year-over-year included (a) additional sources of cash from issuances of short- and long-term debt, net of repayments, proceeds from sales, maturities, calls and redemptions of investments, net of purchases, and issuances of common stock under employee stock plans and (b) increased uses of cash from purchases of subsidiaries, net of cash acquired, the repurchase and retirement of common stock, the purchase of property and equipment, cash dividends, and other uses of cash, net.

 -61-

Financial Condition

We maintained a strong financial condition and liquidity position, with consolidated cash, cash equivalents and investments in fixed maturity and equity securities of $35,716 at December 31, 2024. Since December 31, 2023, total cash, cash equivalents and investments in fixed maturity and equity securities decreased by $1,529, primarily due to cash used for common stock repurchases, purchases of subsidiaries net of cash acquired, purchases of property and equipment and cash dividends paid to shareholders. This decrease was partially offset by cash generated from operations, issuances of short-and-long term debt, net of repayment, proceeds from sales, maturities, calls, and redemptions, and issuances of common stock.

Many of our subsidiaries are subject to various government regulations that restrict the timing and amount of dividends and other distributions that may be paid to their respective parent companies. Certain accounting practices prescribed by insurance regulatory authorities, or statutory accounting practices, differ from GAAP. Changes that occur in statutory accounting practices, if any, or other